Company Filing History:
Years Active: 2022
Title: Innovations of Xiaoying Zhou in Vaccine Adjuvants
Introduction
Xiaoying Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly through his innovative research on adjuvants. His work focuses on enhancing the efficacy of vaccines, which is crucial for public health.
Latest Patents
Xiaoying Zhou holds a patent for a "Mevalonate pathway inhibitor as highly-efficient vaccine adjuvant." This patent discloses inhibitors of the mevalonate pathway that serve as efficient vaccine adjuvants. The specific inhibitors include acetoacetyl-CoA transferase inhibitors, HMG-CoA synthase inhibitors, HMG-CoA reductase inhibitors, mevalonate kinase inhibitors, phosphomevalonate kinase inhibitors, mevalonate-5-pyrophosphate decarboxylase inhibitors, isopentenyl pyrophosphate isomerase inhibitors, farnesyl pyrophosphate synthase inhibitors, geranylgeranyl pyrophosphate synthase inhibitors, and geranylgeranyl transferase inhibitors. Additionally, the patent describes an immunogenic composition that incorporates these inhibitors as an adjuvant.
Career Highlights
Xiaoying Zhou is affiliated with Tsinghua University, where he conducts his research and development activities. His work has garnered attention for its potential to improve vaccine responses, making him a valuable asset in the field of immunology.
Collaborations
Xiaoying Zhou collaborates with notable colleagues, including Yonghui Zhang and Yun Xia. Their combined expertise contributes to advancing research in vaccine adjuvants and related fields.
Conclusion
Xiaoying Zhou's innovative work in developing mevalonate pathway inhibitors as vaccine adjuvants represents a significant advancement in immunology. His contributions are poised to enhance vaccine efficacy and improve public health outcomes.